864 AVA-NP-695, a potent and selective ENPP1 inhibitor, demonstrates strong anti-tumor efficacy as monotherapy and in combination with radiation

• Sandeep Goyal,
• Avijit Goswami,
• Princy Khurana,
• Kawaljit Singh,
• Ishani Ghoshal,
• Aditya Kulkarni

Affiliations

Sandeep Goyal

2Aten Porus Lifesciences, Levittown, PA, USA

Avijit Goswami

1Aten Porus Lifesciences, Pvt., Ltd., Bangalore, Karnataka, India

Princy Khurana

3Avammune Therapeutics, Inc., Levittown, PA, USA

Kawaljit Singh

3Avammune Therapeutics, Inc., Levittown, PA, USA

Ishani Ghoshal

1Aten Porus Lifesciences, Pvt., Ltd., Bangalore, Karnataka, India

Aditya Kulkarni

3Avammune Therapeutics, Inc., Levittown, PA, USA